178 related articles for article (PubMed ID: 15526105)
1. Urotensin II stimulates plasma extravasation in mice via UT receptor activation.
Vergura R; Camarda V; Rizzi A; Spagnol M; Guerrini R; Calo' G; Salvadori S; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):347-52. PubMed ID: 15526105
[TBL] [Abstract][Full Text] [Related]
2. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.
Gendron G; Simard B; Gobeil F; Sirois P; D'Orléans-Juste P; Regoli D
Can J Physiol Pharmacol; 2004 Jan; 82(1):16-21. PubMed ID: 15052301
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).
Camarda V; Spagnol M; Song W; Vergura R; Roth AL; Thompson JP; Rowbotham DJ; Guerrini R; Marzola E; Salvadori S; Cavanni P; Regoli D; Douglas SA; Lambert DG; Calò G
Br J Pharmacol; 2006 Jan; 147(1):92-100. PubMed ID: 16273120
[TBL] [Abstract][Full Text] [Related]
4. A new ligand for the urotensin II receptor.
Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
[TBL] [Abstract][Full Text] [Related]
5. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
[TBL] [Abstract][Full Text] [Related]
6. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
7. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
8. Urotensin II: a novel target in human corpus cavernosum.
d'Emmanuele di Villa Bianca R; Cirino G; Mitidieri E; Coletta C; Grassia G; Roviezzo F; Grieco P; Novellino E; Imbimbo C; Mirone V; Sorrentino R
J Sex Med; 2010 May; 7(5):1778-86. PubMed ID: 19788716
[TBL] [Abstract][Full Text] [Related]
9. A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II-Induced Pressure Response in Mice.
Nishi M; Yonesu K; Tagawa H; Kato M; Marumoto S; Nagayama T
J Cardiovasc Pharmacol; 2019 Jan; 73(1):15-21. PubMed ID: 30608334
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
[TBL] [Abstract][Full Text] [Related]
11. Ligand-supported purification of the urotensin-II receptor.
Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG
Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.
Behm DJ; Harrison SM; Ao Z; Maniscalco K; Pickering SJ; Grau EV; Woods TN; Coatney RW; Doe CP; Willette RN; Johns DG; Douglas SA
Br J Pharmacol; 2003 May; 139(2):464-72. PubMed ID: 12770952
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
[TBL] [Abstract][Full Text] [Related]
14. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenovascular effects of urotensin II and the relevance of the UT receptor.
Tölle M; van der Giet M
Peptides; 2008 May; 29(5):743-63. PubMed ID: 17935830
[TBL] [Abstract][Full Text] [Related]
16. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
18. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts.
Dai HY; Kang WQ; Wang X; Yu XJ; Li ZH; Tang MX; Xu DL; Li CW; Zhang Y; Ge ZM
Regul Pept; 2007 Apr; 140(1-2):88-93. PubMed ID: 17188370
[TBL] [Abstract][Full Text] [Related]
19. Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.
Wang ZJ; Shi LB; Xiong ZW; Zhang LF; Meng L; Bu DF; Tang CS; Ding WH
Peptides; 2006 Apr; 27(4):858-63. PubMed ID: 16325305
[TBL] [Abstract][Full Text] [Related]
20. Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity.
Song W; McDonald J; Camarda V; Calo G; Guerrini R; Marzola E; Thompson JP; Rowbotham DJ; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):148-57. PubMed ID: 16596397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
